Skip to main content
Clinical Trials/NCT06265740
NCT06265740RecruitingNot Applicable

Early Diagnosis of Premature Births by Analysis of the Vaginal Microbiota

University Hospital, Clermont-Ferrand1 site in 1 country150 target enrollmentStarted: March 29, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
Early diagnosis of preterm birth using vaginal microbiota analysis

Study Overview

Brief Summary

Objectives: to assess the relevance of the RiboTaxa algorithm coupled with neural network learning based on analysis of vaginal microbiota metagenomic sequencing data for predicting prematurity in an identified at-risk population.

Study description: Longitudinal follow-up of a cohort of pregnant women, with collection of biological samples, and a posteriori case-control comparison based on the occurrence of an event (premature birth).

Detailed Description

There is currently no reliable clinical or biological diagnosis to predict premature birth. Recent work using metagenomic data analysis coupled with artificial intelligence approaches suggests that there may be a vaginal microbiota signature during pregnancy that correlates with the occurrence of preterm birth. The aim of the study is to use biological samples to confirm the identification of these vaginal microbiota signatures as a means of predicting preterm birth.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pregnant women Admitted to the Clermont-Ferrand University Hospital maternity ward from 14 weeks' gestation onwards
  • For threat of preterm birth (PTB) characterized by contractile activity and/or cervical changes, or for premature rupture of fetal membranes (PROM)
  • And in need of vaginal swabbing
  • Single or multiple pregnancy
  • Able to understand and object to the study
  • Covered by a French social security scheme.
  • Give informed consent for the study

Exclusion Criteria

  • Patient under guardianship, curatorship or safeguard of justice
  • Patient having received antibiotic therapy in the 2 weeks prior to admission

Arms & Interventions

cohort of pregnant women at -risk of preterm delivery

Other

vaginal swab

Intervention: vaginal swab (Other)

Outcomes

Primary Outcomes

Early diagnosis of preterm birth using vaginal microbiota analysis

Time Frame: at birth

prematurity yes/no (define by birth \<37WG)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials